Inventory / revenue moved 384 bp higher
Inventory / revenue changed +384 basis points from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory / revenue changed +384 basis points from the comparable as-filed period.
Cash / debt changed +854 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Debt / revenue changed -2241 basis points from the comparable as-filed period.
Working capital / assets changed +575 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Current long-term debt changed +17.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Current ratio changed +15.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Free-cash-flow margin changed +321 basis points from the comparable as-filed period.
Capital expenditure changed -29.1% from the comparable as-filed period.
Working capital changed +102.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change.
Capex / revenue changed -144 basis points from the comparable as-filed period.
Cash & equivalents changed +9.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Trade receivables changed +13.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Current liabilities changed +5.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Shares outstanding changed -1.7% from the comparable as-filed period. The change ranks at the 0th percentile of 8 prior comparable changes.
SBC / revenue changed -26 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
R&D / revenue changed +129 basis points from the comparable as-filed period.
Operating cash-flow margin changed +178 basis points from the comparable as-filed period.
Selling, general & administrative changed +10.5% from the comparable as-filed period.
Cost of revenue changed +8.6% from the comparable as-filed period.
Receivables / revenue changed -61 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Stock-based compensation changed +7.4% from the comparable as-filed period.
Operating cash flow / net income changed -3.0% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.